BioTelemetry, Inc. Names Dr. Andrei Stoica Chief Technology Officer
April 07 2020 - 10:29AM
BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical
technology company focused on the delivery of health information to
improve quality of life and reduce cost of care, announced today
that Dr. Andrei Stoica has been named Chief Technology Officer of
the company. Dr. Stoica will lead the company’s global
technology and product development operations, reporting to Joseph
H. Capper, President and Chief Executive Officer.
“We are delighted to welcome Andrei to our BioTelemetry team
during this transformational time of growth and innovation,” said
Joseph H. Capper, President and Chief Executive Officer of
BioTelemetry. “His extensive expertise in enterprise
technology solutions, including cloud platforms, information
security, and software and product development, will be
instrumental as we continue to create best-in-class solutions
across our product and service offerings.”
Since 2006, Dr. Stoica held various leadership positions at
IQVIA, most recently serving as its SVP, IT Systems Development,
leading the development of the global data and AI/ML cloud
platform. His appointments prior to IQVIA include information
technology positions in the health IT industry as well as research
and teaching positions in academia. Dr. Stoica holds a Ph.D.
in Computer Science and Engineering from the University of South
Carolina. He has served on multiple committees and authored
numerous papers, and has been recognized and awarded for his use of
technology innovation to evolve enterprise IT.
“This is an exciting time for BioTelemetry, and I am looking
forward to working with a team that shares my passion for
leveraging technology and innovation to address today’s healthcare
challenges and save lives,” said Dr. Stoica. “BioTelemetry is
an established leader in connected health, and we are uniquely
positioned to offer a continuum of solutions that truly makes a
difference for our patients and customers. Our IoT cloud
platform and clinical subject matter expertise already provides a
differentiating capability to aid physicians in making informed
decisions about patient treatments, and our platforms will
constantly improve powered by AI/ML technologies.”
About BioTelemetry
BioTelemetry, Inc. is the leading remote medical technology
company focused on the delivery of health information to improve
quality of life and reduce cost of care. We provide remote
cardiac monitoring, centralized core lab services for clinical
trials, remote blood glucose monitoring, and original equipment
manufacturing that serves both healthcare and clinical research
customers. More information can be found
at www.gobio.com.
Contact: |
|
BioTelemetry, Inc. |
|
|
Heather C.
Getz |
|
|
Investor
Relations |
|
|
Executive
Vice President, Chief Financial Officer |
|
|
800-908-7103 |
|
|
investorrelations@biotelinc.com |
|
|
|
|
|
BioTelemetry, Inc. |
|
|
Amy M.
Knapp |
|
|
Media
Relations |
|
|
Vice
President, Corporate Communications |
|
|
813-277-8456 |
|
|
amy.knapp@gobio.com |
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From May 2024 to Jun 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Jun 2023 to Jun 2024